β-Lapachone is a naturally occurring quinine, originally isolated from the bark of the lapacho tree (Tabebuia avellanedae) which is currently being evaluated in clinical trials for the treatment of cancer. In addition, recent investigations suggest its potential application for treatment of inflammatory diseases. Multiple sclerosis (MS) is an autoimmune disorder characterized by CNS inflammation and demyelination. Reactive T cells including IL-17 and IFN-γ-secreting T cells are believed to initiate MS and the associated animal model system experimental autoimmune encephalomyelitis (EAE). IL-12 family cytokines secreted by peripheral dendritic cells (DCs) and CNS microglia are capable of modulating T-cell phenotypes. The present studies demonstrated that β-lapachone selectively inhibited the expression of IL-12 family cytokines including IL-12 and IL-23 by DCs and microglia, and reduced IL-17 production by CD4 + T-cells indirectly through suppressing IL-23 expression by microglia. Importantly, our studies also demonstrated that β-lapachone ameliorated the development on EAE. β-Lapachone suppression of EAE was associated with decreased expression of mRNAs encoding IL-12 family cytokines, IL-23R and IL-17RA, and molecules important in Toll-like receptor signaling. Collectively, these studies suggest mechanisms by which β-lapachone suppresses EAE and suggest that β-lapachone may be effective in the treatment of inflammatory diseases such as MS.
Introduction
MS is believed to be an organ-specific autoimmune disease, characterized pathologically by cell-mediated inflammation, demyelination and variable degrees of axonal loss (Lim and Giovannoni, 2005) . It is generally believed that T lymphocytes react against myelin components, leading to damaged myelin sheaths with impaired nerve conduction (Hohlfeld and Wekerle, 2001 ). However, pathological features of MS have also been attributed to antigen presenting cells (APCs) such as peripheral DCs and CNS-resident microglia. APCs are likely to participate in the presentation of myelin proteins to T cells and subsequently contribute to T cell activation (Miller et al., 2007) .
The pathogenesis of many autoimmune diseases including MS is dependent on activation of CD4 + T cells. CD4 + T cells exhibit distinct patterns of cytokine production and include T-helper 1 (Th1), T-helper 2 (Th2), and T-helper 17 (Th17) cells, which are believed to derive from a common precursor. Th1 cells produce IL-2, IFN-γ, and TNF-β. Th2 cells are characterized by the production of IL-4, IL-5, IL-10, and IL-13. Th17 cells produce IL-17, IL-21, IL-22, and GM-CSF.
In EAE, Th1 and Th17 cells are believed to be encephalitogenic, while Th2 cells may be protective (Olsson, 1995) . APCs play important roles in T cell activation, and expansion of T cell subsets. DCs and microglia are sources of proinflammatory cytokines and chemokines including TNF-α, IL-1β, MCP-1 and IL-12 family cytokines (Benveniste, 1997). Chemokines play important roles in recruiting cells to sites of inflammation in the CNS. IL-12 family cytokines which include IL-12, IL-23, and IL-27 play critical roles in T cell differentiation and are important modulators of MS and EAE. IL-12 family cytokines are heterodimeric proteins with IL-12 composed of p40 and p35 subunits, and IL-23 composed of the same p40 subunit together with a unique p19 subunit. IL-27 is composed of Epstein-Barr virus-induced molecule 3 (EBI3) and p28 (Trinchieri et al., 2003) . Initial studies indicated that IL-12p 40 −/− mice were resistant to EAE, which suggests a critical role for IL-12 in disease development. However, later studies indicated that IL-12 p35 −/− mice were susceptible to the development of EAE (Gran et al., 2002) , while IL-23 p19 −/− mice did not develop disease (Cua et al., 2003) . Collectively, these studies define a critical role for IL-23 in the pathogenesis of EAE. It has been recognized for some time that CD4 + Th1 cells which are characterized by production of IFN-γ play a critical role in the development of EAE. Furthermore, IL-12 is known to contribute to the generation of Th1 cells (Murphy and Reiner, 2002; Trinchieri et al., 2003 
